LifeMD, Inc. (LFMDP)
USD 22.12
(1.28%)
USD 22.12
(1.28%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 126.01 Million USD | 25.56% |
| 2022 | 100.36 Million USD | 34.03% |
| 2021 | 74.88 Million USD | 163.79% |
| 2020 | 28.38 Million USD | 208.62% |
| 2019 | 9.19 Million USD | 44.73% |
| 2018 | 6.35 Million USD | 77.96% |
| 2017 | 3.57 Million USD | 8.46% |
| 2016 | 3.29 Million USD | 239.06% |
| 2015 | 971.09 Thousand USD | 79.4% |
| 2014 | 541.3 Thousand USD | -13.68% |
| 2013 | 627.05 Thousand USD | 14.39% |
| 2012 | 548.15 Thousand USD | 9.07% |
| 2011 | 502.56 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 37.69 Million USD | 0.67% |
| 2024 Q2 | 42.9 Million USD | 13.81% |
| 2023 Q1 | 28.91 Million USD | 20.2% |
| 2023 Q3 | 33.83 Million USD | 7.75% |
| 2023 Q4 | 37.44 Million USD | 10.68% |
| 2023 FY | 126.01 Million USD | 25.56% |
| 2023 Q2 | 31.39 Million USD | 8.6% |
| 2022 FY | 100.36 Million USD | 34.03% |
| 2022 Q1 | 23.79 Million USD | 8.9% |
| 2022 Q2 | 25.82 Million USD | 8.53% |
| 2022 Q3 | 26.69 Million USD | 3.38% |
| 2022 Q4 | 24.05 Million USD | -9.9% |
| 2021 Q4 | 21.84 Million USD | 10.07% |
| 2021 Q1 | 14.93 Million USD | 67.65% |
| 2021 Q2 | 18.11 Million USD | 21.28% |
| 2021 Q3 | 19.85 Million USD | 9.59% |
| 2021 FY | 74.88 Million USD | 163.79% |
| 2020 Q4 | 8.9 Million USD | 7.71% |
| 2020 Q1 | 2.54 Million USD | -5.28% |
| 2020 Q2 | 6.89 Million USD | 171.08% |
| 2020 Q3 | 8.27 Million USD | 19.87% |
| 2020 FY | 28.38 Million USD | 208.62% |
| 2019 Q3 | 2.44 Million USD | 19.75% |
| 2019 Q4 | 2.68 Million USD | 9.83% |
| 2019 FY | 9.19 Million USD | 44.73% |
| 2019 Q2 | 2.04 Million USD | 1.1% |
| 2019 Q1 | 2.02 Million USD | 30.78% |
| 2018 Q1 | 1.25 Million USD | 18.52% |
| 2018 FY | 6.35 Million USD | 77.96% |
| 2018 Q4 | 1.54 Million USD | -24.82% |
| 2018 Q3 | 2.05 Million USD | 36.78% |
| 2018 Q2 | 1.5 Million USD | 20.13% |
| 2017 Q1 | 221.1 Thousand USD | -28.25% |
| 2017 Q2 | 778.17 Thousand USD | 251.95% |
| 2017 Q4 | 1.05 Million USD | -30.38% |
| 2017 FY | 3.57 Million USD | 8.46% |
| 2017 Q3 | 1.51 Million USD | 94.84% |
| 2016 Q1 | 303.08 Thousand USD | -16.57% |
| 2016 FY | 3.29 Million USD | 239.06% |
| 2016 Q3 | 441.69 Thousand USD | -16.07% |
| 2016 Q2 | 526.27 Thousand USD | 73.64% |
| 2016 Q4 | 308.16 Thousand USD | -30.23% |
| 2015 FY | 971.09 Thousand USD | 79.4% |
| 2015 Q4 | 363.28 Thousand USD | 76.44% |
| 2015 Q3 | 205.89 Thousand USD | 9.61% |
| 2015 Q2 | 187.85 Thousand USD | -12.24% |
| 2015 Q1 | 214.06 Thousand USD | 50.06% |
| 2014 Q1 | 143.33 Thousand USD | 38.62% |
| 2014 Q4 | 142.64 Thousand USD | 51.97% |
| 2014 Q3 | 93.86 Thousand USD | -26.36% |
| 2014 Q2 | 127.45 Thousand USD | -11.08% |
| 2014 FY | 541.3 Thousand USD | -13.68% |
| 2013 Q3 | 77.2 Thousand USD | -69.99% |
| 2013 Q2 | 257.23 Thousand USD | 29.96% |
| 2013 Q1 | 197.92 Thousand USD | 9.52% |
| 2013 Q4 | 103.4 Thousand USD | 33.94% |
| 2013 FY | 627.05 Thousand USD | 14.39% |
| 2012 FY | 548.15 Thousand USD | 9.07% |
| 2012 Q1 | 148.96 Thousand USD | 0.0% |
| 2012 Q2 | 123.76 Thousand USD | -16.92% |
| 2012 Q3 | 98.26 Thousand USD | -20.61% |
| 2012 Q4 | 180.71 Thousand USD | 83.92% |
| 2011 FY | 502.56 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -105.67 Thousand USD | 119346.992% |
| BIMI International Medical Inc. | 1.94 Million USD | -6362.435% |
| China Jo-Jo Drugstores, Inc. | 31.1 Million USD | -305.079% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 90.55 Million USD | -39.161% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.55 Million USD | -39.161% |
| Leafly Holdings, Inc. | 37.45 Million USD | -236.478% |
| Leafly Holdings, Inc. | 37.45 Million USD | -236.478% |
| LifeMD, Inc. | 126.01 Million USD | 0.0% |
| TRxADE HEALTH, Inc. | 2.59 Million USD | -4749.954% |
| PetMed Express, Inc. | 78.64 Million USD | -60.226% |
| Walgreens Boots Alliance, Inc. | 26.52 Billion USD | 99.525% |